Comment on The Study of NRG258: Limitations and Future Directions

Affiliations

¹ Yue-Can Zeng, MD, PhD, Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University, Haikou, China; Ming Xue, MS, Department of Outpatient, The Second Affiliated Hospital of Hainan Medical University, Haikou, China; Jun-Nv Xu, MD, PhD and Nan-Nan Ji, MD, Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University, Haikou, China; and Yi Wang, MD, PhD, Department of Transplant Surgery, the Second Affiliated Hospital of Hainan Medical University, Haikou, China.

Yue-Can Zeng et al. J Clin Oncol. 2025.

. 2025 Jul 20;43(21):2449-2450.

doi: 10.1200/JCO-24-02826. Epub 2025 Apr 10.

¹ Yue-Can Zeng, MD, PhD, Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University, Haikou, China; Ming Xue, MS, Department of Outpatient, The Second Affiliated Hospital of Hainan Medical University, Haikou, China; Jun-Nv Xu, MD, PhD and Nan-Nan Ji, MD, Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University, Haikou, China; and Yi Wang, MD, PhD, Department of Transplant Surgery, the Second Affiliated Hospital of Hainan Medical University, Haikou, China.

No abstract available

Publication types